STAT+: Pharmalittle: We’re reading about a bill to overhaul the 340B program, a new FDA commissioner candidate, and more

▤ Summary

This item covers two main healthcare policy developments: a Senate bill to overhaul the 340B drug discount program and a possible new FDA commissioner candidate. The 340B proposal would add restrictions that affect how nonprofit hospitals receive and pass through drug discounts, and it would also tighten rules for contract pharmacies. The article also highlights Jeff Vacirca as a finalist under consideration to lead the FDA. The piece is broad industry news rather than a direct software-company event, though it may matter to healthcare and pharma vendors watching regulatory shifts.

▦ Linked Companies